Eighteen months after Sanofi discontinued marketing Auvi-Q (epinephrine auto-injector), it has filed an antitrust suit against Mylan NV claiming the EpiPen maker blocked its access to the market.
The complaint, filed April 24 in the US District Court for the District of New Jersey, alleges that...





